Addex Therapeutics Ltd (SWX: ADXN)
Switzerland
· Delayed Price · Currency is CHF 0.0562
-0.0036 (-6.02%)
Nov 21, 2024, 3:45 PM CET
Addex Therapeutics Cash Flow Statement
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 4.32 | -10.56 | -20.8 | -15.35 | -12.86 | -14.78 | Upgrade
|
| Depreciation & Amortization | 0.42 | 0.31 | 0.32 | 0.35 | 0.38 | 0.33 | Upgrade
|
| Stock-Based Compensation | 1.76 | 1.79 | 3.68 | 1.34 | 1.46 | 1.98 | Upgrade
|
| Other Operating Activities | -0 | 0.25 | 0.2 | -0.28 | 0.66 | 0.33 | Upgrade
|
| Change in Accounts Receivable | -0.12 | 0.45 | -0.27 | -0.26 | 0.05 | 0.15 | Upgrade
|
| Change in Accounts Payable | -1.06 | -0.61 | -0.43 | 0.88 | -1.59 | 1.97 | Upgrade
|
| Change in Unearned Revenue | 0.29 | 0.32 | - | -0.82 | -0.46 | 1.06 | Upgrade
|
| Change in Other Net Operating Assets | 0.52 | 0.06 | 0.86 | -0.57 | 0.17 | -0.53 | Upgrade
|
| Operating Cash Flow | -7.83 | -7.99 | -16.44 | -14.71 | -12.18 | -9.48 | Upgrade
|
| Capital Expenditures | -0 | -0.01 | -0 | -0.03 | -0.06 | -0.03 | Upgrade
|
| Investment in Securities | - | - | 0 | 0 | - | -0.01 | Upgrade
|
| Other Investing Activities | 4.67 | - | - | - | - | - | Upgrade
|
| Investing Cash Flow | 4.67 | -0.01 | 0 | -0.03 | -0.06 | -0.04 | Upgrade
|
| Long-Term Debt Repaid | - | -0.28 | -0.29 | -0.31 | -0.37 | -0.32 | Upgrade
|
| Net Debt Issued (Repaid) | -0.21 | -0.28 | -0.29 | -0.31 | -0.37 | -0.32 | Upgrade
|
| Issuance of Common Stock | 0.29 | 2.39 | 1.7 | 13.96 | 0.72 | 0.01 | Upgrade
|
| Repurchase of Common Stock | -0.05 | -0.05 | -0.31 | -0.39 | - | - | Upgrade
|
| Other Financing Activities | -0.17 | 3.21 | 2 | 3.14 | -0.31 | -0.15 | Upgrade
|
| Financing Cash Flow | -0.14 | 5.26 | 3.1 | 16.4 | 0.05 | -0.46 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.08 | -0.36 | -0.2 | 0.12 | -0.65 | -0.14 | Upgrade
|
| Net Cash Flow | -3.38 | -3.09 | -13.53 | 1.79 | -12.84 | -10.13 | Upgrade
|
| Free Cash Flow | -7.83 | -8 | -16.44 | -14.74 | -12.24 | -9.51 | Upgrade
|
| Free Cash Flow Margin | -906.88% | -485.67% | -1137.59% | -467.34% | -315.52% | -335.63% | Upgrade
|
| Free Cash Flow Per Share | -0.09 | -0.11 | -0.36 | -0.43 | -0.46 | -0.36 | Upgrade
|
| Cash Interest Paid | 0.02 | 0.02 | 0.05 | 0.06 | 0.07 | 0.13 | Upgrade
|
| Levered Free Cash Flow | -5.81 | -4.22 | -9.12 | -8.2 | -7.85 | -4.33 | Upgrade
|
| Unlevered Free Cash Flow | -5.79 | -4.21 | -9.09 | -8.16 | -7.81 | -4.24 | Upgrade
|
| Change in Net Working Capital | 0.96 | -0.13 | 0.27 | 0.13 | 1.94 | -2.6 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.